Corvus Pharmaceuticals, Inc.
SEC Filing List
CRVS CIK: 0001626971
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Corvus Pharmaceuticals, Inc. | GLOBENEWSWIRE INC. /fa | 06/12/2026 | |
| 4 | Statement of changes in beneficial owner... | Miller Richard A Md | Latham & Watkins LLP (Filing Agent) /fa | 05/20/2026 | |
| SCHEDULE 13G/A | SEWARD & KISSEL LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G | SEWARD & KISSEL LLP /fa | 05/15/2026 | |||
| 8-K | Current report filing | Corvus Pharmaceuticals, Inc. | GLOBENEWSWIRE INC. /fa | 05/14/2026 | |
| S-8 | Initial registration statement for secur... | Corvus Pharmaceuticals, Inc. | Toppan Merrill/FA | 05/07/2026 | |
| 8-K | Current report filing | Corvus Pharmaceuticals, Inc. | GLOBENEWSWIRE INC. /fa | 05/07/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Corvus Pharmaceuticals, Inc. | Toppan Merrill/FA | 05/07/2026 | |
| 4 | Statement of changes in beneficial owner... | Chan Andrew C. | Latham & Watkins LLP (Filing Agent) /fa | 04/27/2026 | |
| 3 | Initial statement of beneficial ownershi... | Chan Andrew C. | Latham & Watkins LLP (Filing Agent) /fa | 04/27/2026 | |
| No record found. | |||||
| Load More | |||||
